GPX3 and chronic obstructive pulmonary disease: Our meta-analysis has shown for the first time that GPx-1, but not GPx-3, is significantly lower in COPD patients when compared to non-COPD subjects, and in COPD patients with more severe disease when compared to those with milder forms, which further supports the pathophysiological role of oxidative stress in this disabling condition.